Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus

Clin Auton Res. 2017 Jul;27(Suppl 1):33-34. doi: 10.1007/s10286-017-0435-5. Epub 2017 Jul 3.

Authors

Steven Vernino¹, Daniel Claassen²

Affiliations

¹ Department of Neurology and Neurotherapeutics, UT Southwestern, Dallas, TX, USA. [email protected].
² Department of Neurology, University of Southern California, Los Angeles, CA, USA.

No abstract available

Keywords: Droxidopa; Neurogenic orthostatic hypotension; Parkinson disease; Type 2 diabetes mellitus.

Publication types

Case Reports
Letter

MeSH terms

Aged
Antiparkinson Agents / therapeutic use*
Diabetes Mellitus, Type 2 / complications*
Diabetes Mellitus, Type 2 / drug therapy*
Droxidopa / therapeutic use*
Female
Humans
Hypotension, Orthostatic / complications*
Hypotension, Orthostatic / drug therapy*
Midodrine / therapeutic use
Parkinson Disease / complications*
Parkinson Disease / drug therapy*
Polypharmacy*
Vasoconstrictor Agents / therapeutic use

Substances

Antiparkinson Agents
Vasoconstrictor Agents
Midodrine
Droxidopa